Related Experiment Video
Updated: Jun 12, 2026

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
Published on: January 6, 2023
IL-6 receptor-mediated lung Th2 cytokine networking in silica-induced pulmonary fibrosis
Shambhoo Sharan Tripathi1, Vani Mishra, Mamta Shukla
1Immunobiology Division, Indian Institute of Toxicology Research, Mahatma Gandhi Marg, Lucknow, 226001, India.
Abstract:
Pulmonary silicosis is a deadly disease which kills thousands of people every year worldwide. The disease initially develops as an inflammatory response with recruitment of inflammatory cells into the lung controlled by multiple cytokines. The question whether these cytokines exert biological functions through signal transducing pathway remains unanswered along with the potential role of interleukin-6 receptor α (IL-6Rα) in regulating inflammatory cytokines. We aimed to assess the status of signal transducers and activator of transcription (Stat3), suppressor of cytokine signalling 3(Socs3) and inflammatory cytokines in airways of silica-exposed mice, and their relationship with IL-6Rα. Silica-exposed and silica-exposed IL-6Rα gene knockdown Balb/c mice were used in the study. Lung function was measured by plethysmography, mRNA expression of cytokines and signal molecules by qRT(2)-PCR and lung architecture by histopathology; T helper cell-type 2 (Th2) cytokines in broncho-alveolar lavage fluids were evaluated by ELISA and hydroxyproline in lung by colorimetry. Elevated levels of collagen deposition, signs of lung fibrosis, infiltration of inflammatory cells and presence of exfoliated mucosa in the lung of silica-exposed mice with concurrent increase in methacholine-induced specific resistance of airways were observed on day 60 post-exposure. In parallel, heightened expression of Th2 cytokines (IL-4, IL-5, IL-6) and signal molecules (Stat3 and Socs3) were observed in the airways of silica-exposed mice. Th1 (IL-1β and TNF-α) cytokines are underexpressed in majority of the airways tissues of silica-exposed mice. Silencing IL-6Rα in lung of silica-exposed mice down regulated the hypermorphic mRNA pool of potential Th2 cytokines and signal molecules. Hypermorphic expression of Th2 cytokines and signal molecules in airways of silica-exposed mice are mediated through IL-6Rα.
Insights
Silica exposure causes lung inflammation and fibrosis by increasing Th2 cytokines and signal molecules like Stat3 and Socs3. Interleukin-6 receptor alpha (IL-6Rα) mediates these effects in pulmonary silicosis.
Area of Science:
- Pulmonary immunology
- Toxicology
- Molecular biology
Background:
- Pulmonary silicosis is a fatal lung disease driven by inflammation and cytokine activity.
- The role of signal transduction pathways and interleukin-6 receptor alpha (IL-6Rα) in silicosis pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the expression of signal transducers and activator of transcription (Stat3), suppressor of cytokine signalling 3 (Socs3), and inflammatory cytokines in silica-exposed mice.
- To determine the relationship between these molecules and IL-6Rα in the context of pulmonary silicosis.
Main Methods:
- Utilized silica-exposed and IL-6Rα gene knockdown Balb/c mice models.
- Assessed lung function via plethysmography, mRNA expression via qRT-PCR, and lung architecture via histopathology.
- Quantified Th2 cytokines in broncho-alveolar lavage fluid (ELISA) and hydroxyproline in lung tissue (colorimetry).
Main Results:
- Silica exposure led to lung fibrosis, inflammation, and increased airway resistance.
- Heightened expression of Th2 cytokines (IL-4, IL-5, IL-6) and signal molecules (Stat3, Socs3) was observed in silica-exposed mice.
- Silencing IL-6Rα significantly downregulated Th2 cytokines and signal molecules, indicating IL-6Rα mediates these responses.
Conclusions:
- Hypermorphic expression of Th2 cytokines and signal molecules in silica-induced pulmonary silicosis is mediated through IL-6Rα.
- IL-6Rα plays a critical role in regulating inflammatory responses and fibrotic processes in silicosis.
- Targeting IL-6Rα may offer a therapeutic strategy for managing pulmonary silicosis.

